FEDERATED HERMES, INC. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$46,081,485
-25.0%
1,691,374
-38.7%
0.12%
-19.1%
Q2 2023$61,416,586
+2.7%
2,760,2960.0%0.15%
+1.3%
Q1 2023$59,788,011
-10.0%
2,760,296
-15.6%
0.15%
-18.5%
Q4 2022$66,451,781
-53.3%
3,271,875
-41.1%
0.18%
-55.9%
Q3 2022$142,323,000
+8.1%
5,550,800
+0.2%
0.42%
+16.5%
Q2 2022$131,670,000
+23.3%
5,537,000
+16.8%
0.36%
+48.5%
Q1 2022$106,754,000
+16.6%
4,740,420
+2.5%
0.24%
+41.8%
Q4 2021$91,592,000
+20.5%
4,625,849
+19.8%
0.17%
+17.2%
Q3 2021$75,985,000
-32.0%
3,861,000
-23.9%
0.14%
-30.3%
Q2 2021$111,683,000
-7.5%
5,076,5070.0%0.21%
-11.1%
Q1 2021$120,770,000
-9.1%
5,076,5070.0%0.23%
-14.0%
Q4 2020$132,801,000
+46.8%
5,076,507
-2.3%
0.27%
+28.3%
Q3 2020$90,457,000
+5.6%
5,197,213
+2.0%
0.21%0.0%
Q2 2020$85,684,000
+38.1%
5,094,181
-2.4%
0.21%
+16.5%
Q1 2020$62,028,000
-42.2%
5,216,832
-41.2%
0.18%
-23.8%
Q4 2019$107,380,000
-17.8%
8,874,400
-4.0%
0.24%
-25.5%
Q3 2019$130,631,000
+14.1%
9,241,700
-10.0%
0.32%
+15.5%
Q2 2019$114,512,000
-12.7%
10,270,092
-8.1%
0.28%
-14.5%
Q1 2019$131,210,000
-15.4%
11,176,281
-3.7%
0.32%
-23.2%
Q4 2018$155,040,000
-8.5%
11,604,789
-4.0%
0.42%
+7.1%
Q3 2018$169,499,000
-9.5%
12,089,820
+1.4%
0.40%
-28.1%
Q2 2018$187,384,000
-10.2%
11,920,108
-6.0%
0.55%
-9.4%
Q1 2018$208,697,000
-8.5%
12,686,727
+0.5%
0.61%
-5.8%
Q4 2017$227,990,000
-0.9%
12,624,012
+5.9%
0.64%
-2.6%
Q3 2017$229,975,000
+37.8%
11,915,793
-15.7%
0.66%
+37.5%
Q2 2017$166,879,000
+4.6%
14,142,295
-2.9%
0.48%
+5.5%
Q1 2017$159,550,000
+58.4%
14,557,457
+4.9%
0.46%
+50.7%
Q4 2016$100,754,000
+11.7%
13,878,000
-0.0%
0.30%
+16.2%
Q3 2016$90,220,000
+19.0%
13,879,9680.0%0.26%
+17.6%
Q2 2016$75,785,000
+14.1%
13,879,968
-2.2%
0.22%
+7.3%
Q1 2016$66,406,000
-6.0%
14,189,2450.0%0.21%
-8.0%
Q4 2015$70,662,000
+32.6%
14,189,245
+0.1%
0.22%
+29.5%
Q3 2015$53,303,000
-37.4%
14,176,305
+0.1%
0.17%
-32.2%
Q2 2015$85,097,000
+7.5%
14,159,245
+0.1%
0.26%
+5.8%
Q1 2015$79,192,000
+99.8%
14,141,470
+7.0%
0.24%
+97.5%
Q4 2014$39,637,000
+10.9%
13,212,448
-0.9%
0.12%
+6.1%
Q3 2014$35,740,000
-4.3%
13,335,6900.0%0.12%
-1.7%
Q2 2014$37,340,000
-30.0%
13,335,690
+9.0%
0.12%
-34.3%
Q1 2014$53,340,000
+42.0%
12,233,892
+4.9%
0.18%
+36.9%
Q4 2013$37,559,000
+102.5%
11,664,8760.0%0.13%
+83.1%
Q3 2013$18,547,000
-9.5%
11,664,876
-1.5%
0.07%
-12.3%
Q2 2013$20,488,00011,842,5420.08%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders